
The German government on Tuesday expressed "great concern" over the Israeli parliament's decision to introduce the death penalty for convicted terrorists.
"Understandably, Israel has taken a hard line against terrorism since October 7," said government spokesman Stefan Kornelius in Berlin. "However, the German government views the law passed yesterday with great concern."
Opposition to the death penalty is a fundamental feature of German policy, he said.
The German government is also concerned that such a law "would likely apply exclusively to Palestinians in the Palestinian territories," Kornelius added. "It therefore regrets the Knesset’s decision and cannot endorse it."
The Knesset, Israel's parliament, approved the bill on Monday. It provides that the death penalty or life imprisonment may be imposed for terrorist-motivated murder with the aim of destroying the State of Israel.
Israel abolished the death penalty for murder in 1954 and retained it only in exceptional cases. The execution of the German Nazi criminal Adolf Eichmann in 1962 was the last carried out in Israel.
LATEST POSTS
- 1
4K televisions for Extreme Film Watching Experience - 2
The Job of a Migration Legal advisor: How They Can Help You - 3
Meet the rescue team behind the astronauts as Artemis II's launch approaches - 4
Exclusive new photos from 'Michael' biopic show Jaafar Jackson as King of Pop - 5
Pick Your Top Method for starting the Morning
Farewell, comet 3I/ATLAS! Interstellar visitor heads for the outer solar system after its closest approach to Earth
First SpaceX booster for upgraded Starship fails during test in Texas
Moon fever hits DC as Artemis 2 rocket 'candle' lights up Washington Monument just 1 month before launch (photos)
Crypto Investor’s Family Tied Up and Beaten by Armed Gangs in Their Home
2 of Earth's rarest lightning phenomena captured simultaneously in once-in-a-lifetime photo
An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Youngsters
A Couple of Reasonable Guitars for 2024
German mid-sized firms gloomy on outlook, survey finds
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths













